Delivery Order SPE2DB24D8002-SPE2DB25FJNYP
Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,106.58, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA Troop Support Medical's ECAT...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,298.29, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. It is a firm fixed-price contract with a performance period extending to March 17, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, holding a significant Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,023.85, is for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This contract does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA, providing a wide range of pharmaceutical products, medical supplies, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,116.14 firm fixed price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The award is not set aside and has an ultimate completion date of May 21, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,640.80, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a ceiling value of $2,147.04, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 14, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, holding a...
- The Defense Logistics Agency awarded a $5.74K delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for Xulane 150-35 mcg/day transdermal patches (3-count units). This contract is not set-aside and carries a firm fixed price structure with an ultimate completion date of July 23, 2025. The delivery order was issued on July 22, 2025, and falls under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support...
- This is a federal contract award (SPE2DX15D8003|SPE2DX24F7C1V) from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The $13,204.40 firm fixed-price delivery order contract has a period of performance through December 29, 2023. Dakota Drug, Inc. is a key supplier to DLA, holding a $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a firm fixed price pricing type, a ceiling value of $3,183.12, and a period of performance through January 7, 2025. Dakota Drug, Inc. is the prime contractor and there are no major subcontractors mentioned. This contract is not associated...
- This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJNJM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a ceiling value of $1,915.11 and a performance period ending on March 24, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...